scholarly article | Q13442814 |
P356 | DOI | 10.1007/S12350-016-0448-9 |
P698 | PubMed publication ID | 26902485 |
P2093 | author name string | Milena J Henzlova | |
John A Savino | |||
W Lane Duvall | |||
Alan W Ahlberg | |||
Mridula Rai | |||
Eric L Alter | |||
Julianna Marwell | |||
Waseem Chaudhary | |||
P2860 | cites work | Temporal trends in the frequency of inducible myocardial ischemia during cardiac stress testing: 1991 to 2009 | Q86323672 |
Advanced heart block and unresponsiveness after regadenoson administration during myocardial SPECT study | Q87533104 | ||
Regadenoson and seizures: a real clinical concern | Q87643828 | ||
Asystole following regadenoson infusion in stable outpatients | Q87987956 | ||
The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI | Q22252998 | ||
Myocardial infarction during adenosine stress test | Q28345222 | ||
ST segment elevation during adenosine pharmacological stress testing in a patient with coronary artery disease. | Q37503301 | ||
Serious and potentially life threatening complications of cardiac stress testing: Physiological mechanisms and management strategies | Q38480969 | ||
Use of exercise technetium-99m sestamibi SPECT imaging to detect residual ischemia and for risk stratification after acute myocardial infarction | Q40989046 | ||
Prediction of cardiac events after uncomplicated myocardial infarction: a prospective study comparing predischarge exercise thallium-201 scintigraphy and coronary angiography | Q41443037 | ||
A multi-center assessment of the temporal trends in myocardial perfusion imaging | Q41478646 | ||
Prognostic value of exercise testing soon after myocardial infarction | Q41700162 | ||
Safety of dipyridamole testing in 73,806 patients: the Multicenter Dipyridamole Safety Study | Q42545776 | ||
Acute myocardial infarction during adenosine myocardial perfusion imaging | Q44749107 | ||
Regadenoson induced acute ST-segment elevation myocardial infarction and multivessel coronary thrombosis | Q45834622 | ||
Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results | Q46056351 | ||
Acute myocardial infarction during regadenoson myocardial perfusion imaging | Q46986484 | ||
Is there a role for myocardial perfusion imaging in patients with an elevated high-sensitivity troponin? | Q47742517 | ||
Regadenoson for myocardial perfusion imaging: Is it safe? | Q48271472 | ||
Exercise tests. A survey of procedures, safety, and litigation experience in approximately 170,000 tests | Q52999393 | ||
Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial. | Q53229500 | ||
A multinational study to establish the value of early adenosine technetium-99m sestamibi myocardial perfusion imaging in identifying a low-risk group for early hospital discharge after acute myocardial infarction. | Q53508058 | ||
Exercise testing soon after uncomplicated myocardial infarction. Prognostic value and safety | Q70768676 | ||
Early post-myocardial infarction treadmill stress testing. An accurate predictor of multivessel coronary disease and subsequent cardiac events | Q70783978 | ||
Safety of early intravenous dipyridamole technetium 99m sestamibi SPECT myocardial perfusion imaging after uncomplicated first myocardial infarction. Early Post MI IV Dipyridamole Study (EPIDS) | Q73614691 | ||
Seizures associated with regadenoson: a case series | Q82045461 | ||
Activation of central adenosine A(2A) receptors lowers the seizure threshold of hyperthermia-induced seizure in childhood rats | Q82819108 | ||
P433 | issue | 2 | |
P921 | main subject | biomarker | Q864574 |
P304 | page(s) | 724-734 | |
P577 | publication date | 2016-02-22 | |
P1433 | published in | Journal of Nuclear Cardiology | Q609415 |
P1476 | title | Safety of vasodilator stress myocardial perfusion imaging in patients with elevated cardiac biomarkers | |
P478 | volume | 24 |
Q64929293 | Aminophylline shortage and current recommendations for reversal of vasodilator stress: An ASNC information statement endorsed by SCMR. |
Q88340732 | Influence of hemodialysis on regadenoson clearance in an in vitro hemodialysis model |
Q52584068 | Review of cardiovascular imaging in the Journal of Nuclear Cardiology in 2017. Part 2 of 2: Myocardial perfusion imaging. |
Q87314084 | Safety of stress testing in patients with elevated cardiac biomarkers: Are all modalities created equal? |
Search more.